rent-now

Rent More, Save More! Use code: ECRENTAL

5% off 1 book, 7% off 2 books, 10% off 3+ books

9783540650775

Pet in Oncology: Basics and Clinical Application

by ; ;
  • ISBN13:

    9783540650775

  • ISBN10:

    3540650776

  • Format: Hardcover
  • Copyright: 1999-10-01
  • Publisher: Springer Verlag
  • Purchase Benefits
  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $99.00 Save up to $63.36
  • Digital
    $77.22*
    Add to Cart

    DURATION
    PRICE
    *To support the delivery of the digital material to you, a digital delivery fee of $3.99 will be charged on each digital item.

Summary

PET-Center, Bonn, Germany. Summarizes the basics and the clinical results of Positron-Emissiontomography (PET). Describes the principles of PET and how to incorporate the technique in the clinic. Offers an overview of the physical, biochemical, and clinical principles of PET scanning. Illustrated. Expanded-outline format. DNLM: Neoplasms--radionuclide imaging.

Table of Contents

Part I Priciples
Physical Principles
3(32)
H. Newiger
Y. Hamisch
P. Oehr
J. Ruhlmann
B. Vollet
S. Ziegler
PET Technology
3(7)
H. Newiger
The Physics of Positrons
3(1)
Measurement of Positron Radiation
4(1)
Advantages of PET
4(1)
Production of Positron Emitters
5(1)
Detectors for PET
6(1)
Quantitative Imaging with PET
7(2)
Further Development of PET Technology and Reconstruction Methods
9(1)
Dual Head Coincidence Camera
10(5)
S. Ziegler
Comparison of the Dual Head Coincidence Camera with Other Techniques
10(1)
Measurement Problems
11(4)
Design Considerations of NaI(TI) Based PET Imaging Systems Adressing the Clinical and Technical Requirements of Wholebody PET
15(11)
Y. Hamisch
Introduction
15(1)
Digital Detectors Improve Countrate Capability
15(3)
NaI Detector Technology for Dedicated Pet-Systems
18(1)
Post Injection CS-137 Singles Transmission Improves Clinical Image Quality, Quantitative Accuracy and Enables Flexible Clinical Operation
19(7)
Quality Control
26(9)
B. Vollet
Intergrity Testing for PET Scanners or Gamma Cameras with Integrated Coincidence Acquisition
28(4)
Quality Assurance for Transmission Measurement
32(1)
Integrity Testing for In Vitro Analyzers and Activity Meters
32(1)
Quality Assurance for Documentation of Findings
33(2)
Radiopharmaceutical Technology, Toxicity and Radiation Dosages
35(8)
J. Ruhlmann
P. Oehr
Introduction
35(1)
The Synthesis of 2-[18F]FDG
36(1)
Purity of the 2-[18F]FDG Solution
36(1)
2-[18F]FDG Activity Dosages
37(1)
Radiation Exposure
38(2)
Biochemical Toxicity
40(1)
Conclusions
40(3)
Metabolism and Transport of Glucose and FDG
43(18)
P. Oehr
Biological Functions of Carbohydrate Metabolism
43(2)
Carbohydrate Requirements & Supply
43(1)
Regulation Mechanisms
43(1)
Factors in Glucose Homeostasis
44(1)
Metabolism of Glucose, 2-DG, 2-FDG and 3-FDG
45(1)
Glucose
45(1)
Metabolism of 2-DG, 2-FDG and 3-FDG
46(1)
FDG Uptake
46(15)
Glucose Transport Systems
46(4)
Glucose Transporters in Cancer Diseases
50(1)
Kinetics of Glucose Transport
51(1)
Quantification of PET Measurements
52(9)
Part II Clinical Applications
Patient Preparation
61(6)
B. Kozak
PET Scanning Technique
61(6)
Clinical Indications
67(112)
C. Alexiou
R. An
W. Arnold
M. Bangard
R.P. Baum
H.-J. Biersack
R. Bonnet
U. Bull
U. Cremerius
C.G. Diederichs
F. Grunwald
R.J. Kau
R. Kaufmann
C. Laubenbacher
C. Menzel
P. Oehr
H. Palmedo
N. Presselt
J. Reul
D. Rinne
J. Ruhlmann
M. Schwaiger
P. Willkomm
M. Zimny
Malignant Melanoma
67(9)
D. Rinne
R. Kaufmann
R.P. Baum
Epidemiology
67(1)
Histology and Staging
67(1)
Prognosis
67(1)
Malignant Melanoma Therapy
68(1)
Staging and Follow-Up
68(1)
Indications
69(1)
Summary
69(7)
Head and Neck Tumors
76(13)
C. Laubenbacher
R.J. Kau
C. Alexiou
W. Arnold
M. Schwaiger
Introduction
76(2)
Significance of PET
78(7)
Study Protocol and Interpretation of PET
85(2)
Summary
87(2)
Thyroid Carcinomas
89(13)
F. Grunwald
Clinical Background
89(2)
Therapy
91(1)
Use of FDG PET
92(6)
Indications
98(1)
Results and Interpretation
99(1)
Limits of Interpretation
100(2)
Pulmonary Nodules and Non-Small-Cell Bronchial Carcinoma
102(17)
R.P. Baum
N. Presselt
R. Bonnet
Epidemiology and Etiology of Lung Cancer
102(1)
Prognosis, Histology and Staging
103(1)
Diagnosis of Lung Cancer
103(1)
Therapy for Non-Small-Cell Bronchial Carcinoma
104(2)
Positron Emission Tomography
106(2)
Clinical Indications for Positron Emission Tomography
108(7)
Positron Emission Tomography: Limitations and Pitfalls
115(4)
Breast Cancer
119(9)
P. Willkomm
H. Palmedo
M. Bangard
P. Oehr
H.-J. Biersack
Introduction, Clinical Background, Prognosis
119(1)
Technical Aspects
120(1)
Indications
121(5)
Summary
126(2)
Pancreatic Cancer
128(7)
C.G. Diederichs
Clinical Principles
128(1)
Current Therapy
129(1)
PET
129(4)
Other Diagnostic Methods
133(1)
Indications
134(1)
Colorectal Cancer
135(9)
J. Ruhlmann
P. Oehr
Incidence, Etiology and Risk Factors
135(2)
Diagnostics
137(1)
Prognosis, Staging and Tumor Spread
138(1)
Therapy
138(1)
Positron Emission Tomography
139(5)
Ovarian Cancer
144(7)
M. Zimny
U. Cremerius
U. Bull
Epidemiology
144(1)
Pathophysiology and Tumor Spread
145(1)
Histology
145(1)
Tumor Staging
145(1)
Therapy
146(1)
Diagnosis
146(1)
Positron Emission Tomography
146(2)
Results
148(3)
Testicular Tumors
151(7)
U. Cremerius
M. Zimny
U. Bull
Clinical Principles and Current Therapy
151(2)
Performing PET Scans
153(1)
Results of PET Scans
153(3)
Indications
156(2)
Hodgkin's Disease and Non-Hodgkin's Lymphomas
158(7)
C. Menzel
Hodgkin's Disease
158(1)
Malignant Lymphomas -- Non-Hodgkin's Lymphomas
159(6)
PET and Neuro-Imaging: Diagnostic and Therapeutic Value, Current Applications and Future Perspective
165(6)
J. Reul
Introduction
165(1)
Diagnostic Neuroimaging and Tumour Classification
166(3)
Diagnostic Imaging with PET
169(1)
Conclusion
170(1)
Miscellaneous Tumors
171(8)
H.-J. Biersack
P. Willkomm
R. An
J. Ruhlmann
Brain Tumors
171(1)
Musculoskeletal Tumors
171(1)
Prostate Cancer
172(1)
Bladder Cancer
173(1)
Kidney Tumors
173(1)
Esophageal Cancer
174(1)
Gastric Cancer
175(1)
Liver Cancer
175(4)
Cancer Screening with Whole-Body FDG PET
179(10)
S. Yasuda
M. Ide
A. Shohtsu
Background
179(1)
Cancer Screening with Whole-Body FDG PET
179(8)
Subjects and Methods
179(2)
Results
181(2)
Cancer Screening
183(4)
Conclusions
187(2)
PET and Radiotherapy
189(6)
Val J. Lowe
Introduction
189(1)
PET Before Radiation Therapy
189(1)
PET During Radiation Therapy
190(1)
Reoxygenation and PET
190(1)
PET Imaging After Completion of Radiation Therapy
191(1)
Diagnosing Recurrent Disease with PET
191(1)
Timing of PET After Radiation Therapy
192(1)
Summary
193(2)
Cost Effectiveness of PET in Oncology
195(4)
P.E. Valk
Diagnosis and Staging of Non-Small Cell Lung Cancer
195(1)
Staging of Recurrent Colorectal Cancer
196(1)
Staging of Metastatic Melanoma
197(2)
Subject Index 199

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program